Theodora Oringher is honored to announce the Firm has been named as one of the American Antitrust Institute’s 2025 Antitrust Enforcement Award Honorees in the category of Outstanding Antitrust Litigation Achievement in Private Law Practice.
The American Antitrust Institute (AAI) – a nonprofit dedicated to promoting fair competition and protecting consumers – recognizes a few legal teams each year for their work in significant antitrust cases of nationwide importance. The Firm is being honored this year for our work in Innovative Health LLC v. Biosense Webster, Inc., where Panteha Abdollahi served as local counsel since 2019.
At the heart of the case were allegations that Biosense, a subsidiary of Johnson & Johnson, illegally tied its clinical support services for cardiac mapping systems to the purchase of Biosense’s own sensor-enabled cardiac mapping catheters. This conduct effectively blocked hospitals from using FDA-cleared, lower-cost reprocessed alternatives made by companies like our client, Innovative Health. The case also exposed Biosense’s use of hardware-based blocking technology to exclude competitors like Innovative from the catheter market.
After a two-week trial in the Central District of California in May, the jury unanimously found – in just over two hours – that Biosense violated federal and state antitrust laws, including the Sherman Act, by leveraging its dominance to suppress competition and maintain inflated prices. The jury awarded $147.4 million in damages, later trebled to $442 million under federal and state statutes. Judge Selna also issued a permanent injunction to prevent future misconduct.
This recognition by the AIA demonstrates the meaningful impact of this antitrust case in the healthcare industry.
